Alterations in the substantia nigra and nigrostriatal pathway in different neuroimaging techniques in Parkinson’s disease: an integrative literature review

Authors

DOI:

https://doi.org/10.33448/rsd-v12i1.39591

Keywords:

Substantia nigra; Parkinson’s Disease; Neuroimaging.

Abstract

Objective: The objectives of this review are to describe the primary and most current findings and neuroimaging exams of the substantia nigra and nigrostriatal pathway in Parkinson's disease using different imaging methods, in addition to comparing the favorable and unfavorable results of each study and technique. Methodology: Integrative review using the PubMed database during the period of April 2022, with only articles in the English language and published in the last four years (2018-2022) using the following descriptors “Black substance,” “Parkinson's disease” and “Neuroimaging.” Results: 9 articles were selected for analysis in this work, and among these, five imaging techniques aimed at the substantia nigra and nigrostriatal pathway could be discussed, with three variations of magnetic resonance imaging (MRI) techniques, 1 of Transcranial Ultrasound (TCS) and one cerebral scintigraphy with trodat (Pet or Spec with Trodat). In all studies, excellent results were obtained in terms of accuracy, precision, specificity, and sensitivity. Four of these presented Areas under the Curve above 0.900 and samples ranging from 56 to 3123. Conclusion: The studies analyzed in this review demonstrated consistent and relevant advances in imaging exam options for early diagnosis in PD and evolutionary follow-up of changes related to NS and the nigrostriatal pathway. Neuroimaging techniques have aroused the scientific community's interest in recent years, with great potential, which will provide relevant knowledge for treating this disease, contributing to a better prognosis for patients.

References

Atkinson-Clement, C., Pinto, S., Eusebio, A., & Coulon, O. (2017). Diffusion tensor imaging in Parkinson’s disease: Review and meta-analysis. NeuroImage. Clinical, 16, 98–110. https://doi.org/10.1016/J.NICL.2017.07.011

Barber, T. R., Klein, J. C., Mackay, C. E., & Hu, M. T. M. (2017). Neuroimaging in pre-motor Parkinson’s disease. NeuroImage: Clinical, 15, 215–227. https://doi.org/10.1016/J.NICL.2017.04.011

Cardaioli, G., Ripandelli, F., Paolini Paoletti, F., Nigro, P., Simoni, S., Brahimi, E., Romoli, M., Filidei, M., Eusebi, P., Calabresi, P., & Tambasco, N. (2019). Substantia nigra hyperechogenicity in essential tremor and Parkinson’s disease: a longitudinal study. European Journal of Neurology, 26(11), 1370–1376. https://doi.org/10.1111/ENE.13988

Cheng, Z., He, N., Huang, P., Li, Y., Tang, R., Sethi, S. K., Ghassaban, K., Yerramsetty, K. K., Palutla, V. K., Chen, S., Yan, F., & Haacke, E. M. (2020). Imaging the Nigrosome 1 in the substantia nigra using susceptibility weighted imaging and quantitative susceptibility mapping: An application to Parkinson’s disease. NeuroImage: Clinical, 25, 102103. https://doi.org/10.1016/J.NICL.2019.102103

Deng, X. Y., Wang, L., Yang, T. T., Li, R., & Yu, G. (2018). A meta-analysis of diffusion tensor imaging of substantia nigra in patients with Parkinson’s disease. Scientific Reports, 8(1). https://doi.org/10.1038/s41598-018-20076-y

Frosini, D., Cosottini, M., Volterrani, D., & Ceravolo, R. (2017). Neuroimaging in Parkinson’s disease: Focus on substantia nigra and nigro-striatal projection. Current Opinion in Neurology, 30(4), 416–426. https://doi.org/10.1097/WCO.0000000000000463

Grippe, T. C., Allam, N., Brandão, P. R. de P., Pereira, D. A., Cardoso, F. E. C., Aguilar, A. C. R., & Kessler, I. M. (2018). Is transcranial sonography useful for diagnosing parkinson’s disease in clinical practice? Arquivos de Neuro-Psiquiatria, 76(7), 459–466. https://doi.org/10.1590/0004-282x20180067

Hans, G., Braga, R., Vinicius, J., Chaves, S., Carolina, A., Maia, S., Arthur, D., Cabral, C., Myllena, F., Campos, S., Paulo, J., Medeiros, V., Giovanni, L., Patricio, B., Oliveira, S., Pantoja Braga, J., Jóia De Mello, V., Homero, E., & Paschoal, A. (2022). Parkinson’s disease secondary to COVID-19: a systematic review. Research, Society and Development, 11(1), e50711124397–e50711124397. https://doi.org/10.33448/RSD-V11I1.24397

He, N., Langley, J., Huddleston, D. E., Chen, S., Huang, P., Ling, H., Yan, F., & Hu, X. (2020). Increased iron-deposition in lateral-ventral substantia nigra pars compacta: A promising neuroimaging marker for Parkinson’s disease. NeuroImage. Clinical, 28. https://doi.org/10.1016/J.NICL.2020.102391

Langley, J., Huddleston, D. E., Crosson, B., Song, D. D., Factor, S. A., & Hu, X. (2020). Multimodal assessment of nigrosomal degeneration in Parkinson’s disease. Parkinsonism and Related Disorders, 80, 102–107. https://doi.org/10.1016/j.parkreldis.2020.09.021

Li, D. H., He, Y. C., Liu, J., & Chen, S. di. (2016). Diagnostic Accuracy of Transcranial Sonography of the Substantia Nigra in Parkinson’s disease: A Systematic Review and Meta-analysis. Scientific Reports, 6. https://doi.org/10.1038/SREP20863

Martini, A., Dal Lago, D., Edelstyn, N. M. J., Salgarello, M., Lugoboni, F., & Tamburin, S. (2018). Dopaminergic Neurotransmission in Patients With Parkinson’s Disease and Impulse Control Disorders: A Systematic Review and Meta-Analysis of PET and SPECT Studies. Frontiers in Neurology, 9, 1018. https://doi.org/10.3389/FNEUR.2018.01018/BIBTEX

Perlbarg, V., Lambert, J., Butler, B., Felfli, M., Valabrègue, R., Privat, A. L., Lehéricy, S., & Petiet, A. (2018). Alterations of the nigrostriatal pathway in a 6-OHDA rat model of Parkinson’s disease evaluated with multimodal MRI. PLOS ONE, 13(9), e0202597. https://doi.org/10.1371/JOURNAL.PONE.0202597

Pinheiro, F. E. da S., Brito, B. F. de, Figueiredo, B. Q. de, Soares, C. A. V. D., Júnior, C. A. da S., Alvim, C. M., Prado, D. M. M. do, Lopes, L. F. P., Pereira, M. L. S. A., & Araújo, P. da C. (2022). Use of Deep Brain Stimulation (DBS) for the treatment of Parkinson’s disease: an integrative literature review. Research, Society and Development, 11(8), e40911831277–e40911831277. https://doi.org/10.33448/RSD-V11I8.31277

Pyatigorskaya, N., Magnin, B., Mongin, M., Yahia-Cherif, L., Valabregue, R., Arnaldi, D., Ewenczyk, C., Poupon, C., Vidailhet, M., & Lehéricy, X. S. (2018). Comparative study of MRI biomarkers in the substantia nigra to discriminate idiopathic Parkinson disease. American Journal of Neuroradiology, 39(8), 1460–1467. https://doi.org/10.3174/ajnr.A5702

Saeed, U., Lang, A. E., & Masellis, M. (2020). Neuroimaging Advances in Parkinson’s Disease and Atypical Parkinsonian Syndromes. Frontiers in Neurology, 11, 1189. https://doi.org/10.3389/FNEUR.2020.572976/BIBTEX

Safai, A., Prasad, S., Chougule, T., Saini, J., Pal, P. K., & Ingalhalikar, M. (2020). Microstructural abnormalities of substantia nigra in Parkinson’s disease: A neuromelanin sensitive MRI atlas based study. Human Brain Mapping, 41(5), 1323–1333. https://doi.org/10.1002/hbm.24878

Sales, P. C. S. L., Neto, A. V. de S., Costa, L. A., Fonseca, M. de M. V. da, Mendonça, G. de S., Araújo, L. V. de, Araújo, V. S. C., Cardoso, A. M. S., Jordão, P. V. de S., Araujo, B. D., Filho, C. P. de S., Teixeira, L. R., Ferreira, J. G. de O. R., Pacheco, R. C., Bastos, A. P. S., Cardoso, B. E. M., Araújo, L. S. F. de, Lima, B. S., Pires, V. S., & Souza, L. K. M. de. (2021). Correlation between changes in the gastrointestinal microbiota with the onset and complications of Parkinson’s disease: the role of inflammatory cytokines in the bidirectional gut-brain axis. Research, Society and Development, 10(2), e51310212788–e51310212788. https://doi.org/10.33448/RSD-V10I2.12788

Schwarz, S. T., Abaei, M., Gontu, V., Morgan, P. S., Bajaj, N., & Auer, D. P. (2013). Diffusion tensor imaging of nigral degeneration in Parkinson’s disease: A region-of-interest and voxel-based study at 3 T and systematic review with meta-analysis. NeuroImage. Clinical, 3, 481–488. https://doi.org/10.1016/J.NICL.2013.10.006

Shinde, S., Prasad, S., Saboo, Y., Kaushick, R., Saini, J., Pal, P. K., & Ingalhalikar, M. (2019). Predictive markers for Parkinson’s disease using deep neural nets on neuromelanin sensitive MRI. NeuroImage: Clinical, 22, 101748. https://doi.org/10.1016/J.NICL.2019.101748

Souza, M. T. de, Silva, M. D. da, & Carvalho, R. de. (2010). Integrative review: what is it? How to do it? Einstein (Säo Paulo). http://apps.einstein.br/revista/arquivos/PDF/1134-Einsteinv8n1p102-106.pdf

Tao, A., Chen, G., Deng, Y., & Xu, R. (2019). Accuracy of Transcranial Sonography of the Substantia Nigra for Detection of Parkinson’s Disease: A Systematic Review and Meta-analysis. In Ultrasound in Medicine and Biology (Vol. 45, Issue 3, pp. 628–641). Elsevier USA. https://doi.org/10.1016/j.ultrasmedbio.2018.11.010

Tolosa, E., Wenning, G., & Poewe, W. (2006). The diagnosis of Parkinson’s disease. The Lancet Neurology, 5(1), 75–86. https://doi.org/10.1016/S1474-4422(05)70285-4

Trist, B. G., Hare, D. J., & Double, K. L. (2019). Oxidative stress in the aging substantia nigra and the etiology of Parkinson’s disease. Aging Cell, 18(6). https://doi.org/10.1111/ACEL.13031

Published

03/01/2023

How to Cite

PEREIRA, D. A. .; CHAGAS, M. J. de S. .; SOUZA, L. M. de .; MALFACINI , S. da S. .; ENES, M. de F. G. .; ORSINI, M.; ANTUNES, P. de F. G. . Alterations in the substantia nigra and nigrostriatal pathway in different neuroimaging techniques in Parkinson’s disease: an integrative literature review. Research, Society and Development, [S. l.], v. 12, n. 1, p. e8212139591, 2023. DOI: 10.33448/rsd-v12i1.39591. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/39591. Acesso em: 26 apr. 2024.

Issue

Section

Health Sciences